Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.57 |
| ▸ | MEN1 | O00255 | 7/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.56 |
| ▸ | MAOA | P21397 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | BCL2 | P10415 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.56 |
| ▸ | RECQL | P46063 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | APEX1 | P27695 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.56 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30030177 | 0.83 | ADORA2A (0.68) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL10772648 | 0.75 | MAPT (0.63) | MAPTMEN1KMT2ANPC1RAB9A | |
| Quinalizarin SCHEMBL6746696 | 0.74 | TTR (0.82) | MAPTMEN1KMT2ANPC1RAB9A | |
| Athraquinones A SCHEMBL29373337 | 0.74 | MAPT (1.00) | MAPTMEN1KMT2ANPC1RAB9A | |
| Athraquinones A SCHEMBL21114402 | 0.74 | MAPT (1.00) | MAPTMEN1KMT2ANPC1RAB9A | |
| Athraquinones A SCHEMBL4972786 | 0.74 | MAPT (1.00) | MAPTMEN1KMT2ANPC1RAB9A | |
| Athraquinones A SCHEMBL18614 | 0.74 | MAPT (1.00) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL10489419 | 0.74 | MEN1 (0.55) | MAPTMEN1KMT2ANPC1RAB9A | |
| Quinizarin SCHEMBL25194269 | 0.73 | MEN1 (0.95) | MAPTMEN1KMT2AMCL1MAOA | |
| SCHEMBL11129557 | 0.73 | MAPT (0.57) | MAPTMEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11831017-B2 | Redox flow battery electrolytes | CMBLU ENERGY AG (DE) | 2023-11-28 | — | — | US | disclosed |
| US-20210020943-A1 | Redox Flow Battery Electrolytes | CMBLU ENERGY AG (DE) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11831017-B2 | Redox flow battery electrolytes | GPX1, GPX4, NOX4 | MAPT 3707/4885MEN1 3578/4885KMT2A 3564/4885 |
| US-20210020943-A1 | Redox Flow Battery Electrolytes | GPX1, GPX4, NOX4 | MAPT 3707/4885MEN1 3578/4885KMT2A 3564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.